Summary
This contribution focuses on the role of iron as a critical component in the genesis of oxygen radical mediated tissue injury occurring after global ischemia associated with severe hypovolemic shock. Conventional colloid or crystalloid fluid resuscitation does not adequately protect organs susceptible to reperfusion injury. One approach aimed at attenuating such post-trauma reperfusion injury is systemic, high dose, iron chelation used in combination with colloid fluid replacement.
Similar content being viewed by others
Abbreviations
- DFO:
-
deferoxamine (Desferal®, CIBA-GEIGY)
References
Ambrosio G, Weisfeldt ML, Jacobus WE, et al (1987a) Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide administered at the time of reflow. Circulation 75:282–291
Ambrosio G, Zweier JL, Jacobus WE, et al (1987b) Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 75:906–915
Biemond P, Swaak AJG, Beindorff CM, et al (1986) Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J 239:169–173
Bolli R, Patel BS, Zhu WX, et al (1987) The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 253 (Heart and Circ Physiol 22):H1372-H1380
Bolli R, Jeroudi MO, Patel BS, et al (1989) Marked reduction of free radical generation and contractile dysfunction by anti-oxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res 65:607–622
Bolli R, Patel BS, Jeroudi MO, et al (1990) Iron mediated radical reactions upon reperfusion contribute to myocardial “stunning”. Am J Physiol 259 (Heart Circ Physiol 28):H1901-H1911
Demling RH, Lalonde C, Knox J, et al (1991) Fluid resuscitation with deferoxamine prevents systemic burn induced oxidant injury. J Trauma 31:538–544
Drugas GT, Paidas CN, Yahanda AM, et al (1991) Conjugated deferoxamine attenuates hepatic microvascular injury following ischemia-reperfusion. Circ Shock 34:278–283
Farber NE, Vercellotti GM, Jacob HS, et al (1988) Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res 63:351–360
Forder JR, McClanahan TB, Gallagher KP et al (1990) Hemodynamic effects of intraatrial administration of deferoxamine or deferoxamine-pentafraction conjugate to conscious dogs. J Cardiovasc Pharmacol 16:742–749
Green S and Mazur A (1957) Relation of uric acid metabolism to release of iron from hepatic ferritin. J Biol Chem 219:653–668
Hallaway PE, Eaton JW, Panter SS, et al (1989) Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Nat Acad Sci USA 86:10108–10112
Halliwell B (1989) Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Rad Biol Med 7:645–651
Hernandez LA, Grisham MB, Granger DN (1987) A role for iron in oxidant-mediated ischemic injury to intestinal microvasculature. Am J Physiol 253 (Gastrointest Liver Physiol 16):G49-G53
Holt S, Gunderson M, Joyce K, et al (1986) Myocardial tissue iron delocalization and evidence for lipid peroxidation after two hours of ischemia. Ann Emerg Med 15:1155–1159
Illes RW, Silverman NA, Krukenkamp IB, et al (1989) Amelioration of postischemic stunning by deferoxamine-blood cardioplegia. Circulation 80 (Suppl. III):30–35
Jacobs DM, Julsrud JM and Bubrick MP (1991) Iron chelation with a deferoxamine conjugate in hemorrhagic shock. J Surg Res (In press)
Janoff A, Zweifach BW, Shapiro LR (1960) Levels of plasmabound iron in experimental shock in the rabbit and dog. Am J Physiol 198:1161–1165
Krause GS, Joyce KM, Nayini NR, et al (1985) Cardiac arrest and resuscitation: Brain iron delocalization during reperfusion. Ann Emerg Med 14:1037–1043
Lesnefsky EJ, Repine JE, Horwitz LD (1990) Deferoxamine pretreatment reduces canine infarct size and oxidative injury. J Pharm Exp Therap 253:1103–1109
Mahoney JR, Hallaway PE, Hedlund BE, et al (1989) Acute iron poisoning: Rescue with macromolecular chelators. J Clin Invest 84:1362–1366
Maruyama M, Pieper GM, Kalyanaraman B, et al (1991) Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J Cardiovasc Pharmacol 17:166–175
Mazur A, Baez S, Shorr E (1955) The mechanism of iron release from ferritin as related to its biological properties. J Biol Chem 213:147–160
Mazur A, Green S, Saha A, Carleton A (1958) Mechanism of release of ferritin iron in vivo by xanthine oxidase. J Clin Invest 37:1809–1817
Menasché P, Pasquier C, Bellucci S, et al (1988) Deferoxamine educes neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 96:582–589
Menasché P, Grousset C, Mouas C, et al (1990) A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine. J Thorac Cardiovasc Surg 100:13–21
Palier MS, Hedlund BE (1988) Role of iron in post-ischemic renal injury in the rat. Kidney Int 34, 474–480
Reddy BR, Kloner RA and Przyklenk K (1989) Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Rad Biol Med 7:45–52
Reilly PM, Schiller HJ, Bulkley GB (1991) The pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 161:488–503
Robinson E and Hedlund B (1989) Role of iron in ischemia and reperfusion. Circ Shock 27:367
Sanan S, Sharma G, Malhotra R, et al (1989) Protection by desferrioxamine against histopathological changes of the liver in the post-oligaemic phase of clinical hemorrhagic shock in dogs: Correlation with improved survival rate and recovery. Free Rad Res Commun 6:29–38
Smith SM, Grisham MB, Manci EA et al (1987) Gastric mucosal injury in the rat: Role of iron and xanthine oxidase. Gastroenterology 91:950–956
Thomas CE, Morehouse LA, Aust SD (1985) Ferritin and superoxide dependent lipid peroxidation. J Biol Chem 260:3275–3280
Tsao PS, Lefer AM (1990) Time course and mechanism of endothelial dysfunction in isolated ischemic-and hypoxicperfused rat hearts. Am J Physiol 259 (Heart Circ Physiol 28):H1660-H1666
Williams RE, Zweier JL, Flaherty JT (1991) Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 83:1006–1014
Author information
Authors and Affiliations
Additional information
Manuscripts published in this issue were the matter of a Symposium held at the University of Ulm, April 24–27, 1991
Rights and permissions
About this article
Cite this article
Hedlund, B.E., Hallaway, P.E. Role of iron and oxygen radicals in hemorrhage and shock. Klin Wochenschr 69, 1113–1117 (1991). https://doi.org/10.1007/BF01645169
Issue Date:
DOI: https://doi.org/10.1007/BF01645169